about
Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia ANonsense-mediated mRNA decay among coagulation factor genesEmerging and future therapies for hemophiliaAnimal models of hemophiliaPresent and future challenges in the treatment of haemophilia: the patient's perspectiveImportance of immune response genes in hemophilia ALong-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children. Results of a phase 3 trial.Urine-derived induced pluripotent stem cells as a modeling tool to study rare human diseasesComprehensive analysis of phenotypes and genetics in 21 Chinese families with haemophilia B: characterization of five novel mutations.Molecular diagnosis of haemophilia A at Centro Hospitalar de Coimbra in Portugal: study of 103 families--15 new mutations.Lessons Learned from Animal Models of Inherited Bleeding Disorders.ARFI ultrasound monitoring of hemorrhage and hemostasis in vivo in canine von Willebrand disease and hemophiliaTransplanted endothelial cells repopulate the liver endothelium and correct the phenotype of hemophilia A miceEfficacy, safety and tolerability of recombinant factor VIII (REFACTO) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and Austria.Psychometric properties of the Greek Haem-A-QoL for measuring quality of life in Greek haemophilia patients.Identification of FVIII gene mutations in patients with hemophilia A using new combinatorial sequencing by hybridization.Triggers, targets and treatments for thrombosis.Targeted inversion and reversion of the blood coagulation factor 8 gene in human iPS cells using TALENsAdvancements in gene transfer-based therapy for hemophilia A.Need for Prophylactic Treatment in Adult Haemophilia A PatientsEpidemiology & social costs of haemophilia in IndiaTreatment of hemophilia B: focus on recombinant factor IX.The value of usability testing for Internet-based adolescent self-management interventions: "Managing Hemophilia Online"Consensus review of the treatment of cardiovascular disease in people with hemophilia A and B.piggyBac-mediated phenotypic correction of factor VIII deficiencyPerinatal gene transfer to the liver.Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited.Small ncRNA Expression-Profiling of Blood from Hemophilia A Patients Identifies miR-1246 as a Potential Regulator of Factor 8 GeneExpression and Characterization of Gly-317 Variants of Factor IX Causing Variable Bleeding in Hemophilia B Patients.Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A.Mutation analysis of a cohort of US patients with hemophilia B.Intravascular recovery of VWF and FVIII following intraperitoneal injection and differences from intravenous and subcutaneous injection in mice.Does the genotype predict the phenotype? Evaluations of the hemostatic proteome.Role of bone marrow transplantation for correcting hemophilia A in mice.Molecular Basis and Therapeutic Strategies to Rescue Factor IX Variants That Affect Splicing and Protein FunctionDiscordant fibrin formation in hemophilia.Haemophilia A: from mutation analysis to new therapies.Design and characterization of an APC-specific serpin for the treatment of hemophilia.Haemophilia B: Christmas disease.Adherence to Prophylaxis in Adolescents and Young Adults with Severe Haemophilia: A Quantitative Study with Patients.
P2860
Q26738507-B15B9356-F9EA-4066-BDD1-F6ACA08756F9Q26747371-7551472A-90DD-4354-8821-743724144D4BQ26781143-A5EF20A8-4DD1-4FEE-989F-016CEB09D30EQ27012571-809D59EF-BCAB-4B4C-BD1E-C050C01D240AQ27022801-94BC6C17-0588-41E7-8ED7-8B31480BC099Q27025467-F0A05493-DC02-4644-8A3C-9B57F6E02EE3Q27342796-C5883821-5CC4-48F9-AEE9-B940F2BC0565Q28073204-5A40D742-7FDF-4C57-BBE3-145BA9B4544FQ30367118-153F4B84-3F3E-4C2A-A84E-AA3E4B338824Q30403462-DA85E290-1FA0-4299-B4A5-3B4D8C5EB138Q30409863-00050905-BE76-4486-A616-29793C49ED27Q30443003-F48B0491-936C-49F7-B832-1BB2C702F793Q30481282-762B045B-5006-485F-95D7-328E9D2ECDAEQ31098999-B636EFB3-2B48-4343-AD2F-27AD7A07BA22Q33634745-73810EA8-3D9A-491B-80E6-ABFC2CA09507Q33735836-E5100E0A-C1B5-4A4C-9F01-4F22F091EDB8Q33765444-454D920B-A2D7-4DAF-BD56-853D759B6E74Q33834954-C61657B4-93A5-45F5-85C0-19E621625AA1Q33923877-011B720F-24F1-45D9-AD9B-B6F7092D10DEQ34139334-47E965B4-EEE9-4600-9731-893CF4209786Q34272118-A987B535-59C0-4EE8-A8AE-66160C5942C4Q34329068-DAA0D49C-42FA-4155-8A8B-D6519B0C45A4Q35008183-11329C8D-9605-4F90-AD84-A3B782886730Q35069871-D6DE6E39-9384-4ECA-AB34-89E9E4041D51Q35184221-FB7DE9DE-E4A9-4740-B8B3-04D64F07E348Q35238390-C4F96D2A-BA06-44E9-9455-21CF9D541011Q35690807-AC4574DE-DD64-4955-A308-0325CF37BB08Q35692013-B4F1EADE-1170-4CCA-B1C4-7555B7FB07B9Q35778746-453E8281-0153-49CE-8CCC-57F18DDD33DAQ35818302-3BA0FD46-1416-4FD5-AC26-6433E7BB6900Q35857102-71C5B67B-DBBD-4300-A331-57DAAEBCB879Q35881502-65D9633F-DFC6-441F-B97B-21EBA25D1579Q35904936-91B9C41D-E266-4776-AFF1-0E8DDD4945BCQ36015228-46BB0F3D-D7B3-43DC-8A39-690F51A188DAQ36030221-807D87BE-3393-4582-AE9D-3DE4EB3B3CD7Q36105820-676AE986-BB4C-4AF2-AC45-F79443AABBCAQ36148386-40CF252F-64B3-418E-B715-4A018EB5D937Q36176667-4409D7AB-E118-49D8-BF26-1273954A3855Q36221979-82B04CF9-078A-400A-BAA0-3C3FDC4603EEQ36253858-8C5B5240-C1E0-4B73-993A-DCA001B992F4
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Haemophilias A and B.
@ast
Haemophilias A and B.
@en
type
label
Haemophilias A and B.
@ast
Haemophilias A and B.
@en
prefLabel
Haemophilias A and B.
@ast
Haemophilias A and B.
@en
P1433
P1476
Haemophilias A and B.
@en
P2093
K John Pasi
Paula H B Bolton-Maggs
P304
P356
10.1016/S0140-6736(03)13405-8
P407
P577
2003-05-01T00:00:00Z